PCME is an accredited provider specializing in innovative continuing medical education solutions.

BRIDGING TREATMENT GAPS IN ACUTE AND CHRONIC HEART FAILURE: TRANSLATING CLINICAL EVIDENCE INTO IMPROVED OUTCOMES. A CME SATELLITE BREAKFAST SYMPOSIUM.
EXPIRED

PROGRAM DESCRIPTION

Studies have routinely demonstrated improved patient outcomes when patients are treated following established evidence-based clinical practice guidelines. There is a disparity, however, on the uniform understanding and implementation of these recommendations by clinicians. This symposium will utilize case-based treatment scenarios, as supported by established recommendations, to build a greater understanding of how heart failure guidelines should guide clinical practice.

This program will use case-based clinical scenarios to facilitate the translation of evidence-based heart failure guidelines into clinical practice. The program will also evaluate current unmet needs in heart failure care, the role of new drug entities, and their potential impact on future guideline development.

Faculty

Gregg C. Fonarow, MD (Chair)Gregg C. Fonarow, MD (Chair) (read bio)
Professor of Medicine, UCLA Division of Cardiology
Director, Ahmanson-UCLA Cardiomyopathy Center
Co-Director, UCLA Preventative Cardiology Program
Associate Chief, UCLA Division of Cardiology
The Eliot Corday Chair in Cardiovascular Medicine and Science
Los Angeles, CA

Clyde W. Yancy, MD, FACC, FAHA, MACPClyde W. Yancy, MD, FACC, FAHA, MACP (read bio)
Medical Director, Baylor Heart and Vascular Institute
Chief, Cardiothoracic Transplantation
Baylor University Medical Center
Dallas, TX

Ileana L. Pina, MD, FACCIleana L. Piña, MD, FACC (read bio)
Professor of Medicine
Case Western Reserve University
VA Quality Scholar
Cleveland, OH

TARGET AUDIENCE

This program is intended for cardiologists and other health care professionals.

EDUCATIONAL OBJECTIVES

This activity was designed to address the following IOM competencies: employ evidence-based practice.

At the conclusion of this activity, participants should be able to:

  1. Translate evidence-based guidelines into clinical management of heart failure patients
  2. Discuss current and emerging treatment options for therapeutic and symptomatic management in heart failure patients
  3. Identify barriers and solutions to multidisciplinary management of heart failure patients

ACCREDITATION

PCME LogoThe Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT

The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

DISCLOSURE INFORMATION

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME, as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Gregg C. Fonarow, MD: Speaker: Medtronic, GlaxoSmithKline, AstraZeneca, Pfizer, Novartis, Sanofi-Aventis, Merck-Schering Plough, Bristol-Myers Squibb; Consultant: Medtronic, GlaxoSmithKline

Clyde W. Yancy, MD, FACC, FAHA, MACP: Nothing to Disclose

Ileana L. Piña, MD, FACC: Speaker: AstraZeneca, Innovia, Merck, Solvay, Sanofi-Aventis, Novartis

Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Laurie Frueh, MD; Carole Drexel, PhD; Donna Fucello; Blair St. Amand; Dana Simpler, MD: Nothing to Disclose

FDA Disclosure

The contents of some CME/CE activities may contain discussions of non-approved or off label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

 

Sponsored by
PCME Logo

Supported by an educational grant from
Astellas Pharma US, Inc. and Otsuka America Pharmaceutical, Inc.

Additional support provided by St. Jude Medical, Inc.

By clicking this button you are agreeing that you have read and understood the CME Statements above.

Register Now

Off buttonOn Button